Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8481 - 8488 of 12011 results
Agencies Engaged in Federal Biotech Overhaul to Host Final Two Public Sessions in March
February 28, 2016| Blog| Viewpoint
New GE Ingredient Labeling Bill Intensifies Food Fight in Congress
February 26, 2016| Blog| Viewpoint
US Consulates in Canada Expand E-1/E-2 Visa Processing
February 26, 2016| Blog| Viewpoint
California by the Numbers (Part 2): How to Stay out of the 2017 Report
February 26, 2016| Blog| Viewpoint
The Medicare Overpayment Rule: Implications for Compliance and Health Care Enforcement
February 26, 2016| News
A One-Way Street: EEOC Unveils Nationwide Procedures for Releasing Employers’ Position Statements
February 25, 2016| Blog| Viewpoint
Monumental Year for U.S. Solar Market in 2015
February 25, 2016| Blog| Viewpoint
Draft Treasury Legislation Would Give Puerto Rico Access to “Super Chapter 9” and Chapter 9 Bankruptcy
February 25, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|